Broadfin Capital’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-672,922
Closed -$26.9M 79
2015
Q4
$26.9M Sell
672,922
-948,910
-59% -$33.1M 1.94% 15
2015
Q3
$46.2M Sell
1,621,832
-138,687
-8% -$4.57M 3.68% 8
2015
Q2
$58M Sell
1,760,519
-50,000
-3% -$1.55M 3.81% 8
2015
Q1
$52.1M Sell
1,810,519
-256,200
-12% -$7.35M 4.16% 6
2014
Q4
$56.3M Sell
2,066,719
-13,800
-0.7% -$329K 4.93% 4
2014
Q3
$44.3M Hold
2,080,519
4.65% 5
2014
Q2
$46.7M Buy
2,080,519
+275,167
+15% +$6.41M 4.56% 4
2014
Q1
$45.6M Buy
1,805,352
+731,304
+68% +$18.5M 4.42% 4
2013
Q4
$24.7M Sell
1,074,048
-200
-0% -$4.17K 3.26% 10
2013
Q3
$20.5M Hold
1,074,248
3.63% 8
2013
Q2
$15.5M Buy
+1,074,248
New +$15.6M 3.03% 13

Other funds holding EBS